X4 Pharmaceuticals, Inc Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • X4 Pharmaceuticals, Inc Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.45 USD/shares.
  • X4 Pharmaceuticals, Inc Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 0.11 USD/shares.
  • X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2023 was -0.57 USD/shares, a 62.5% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2022 was -1.52 USD/shares, a 61.9% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Earnings Per Share, Basic for 2021 was -3.99 USD/shares, a 29.1% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.95 +62.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$2 +$2.47 +61.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$4 -$1 -29.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$3 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.